Haystack Oncology

Who we are

The Founders

Powered by pioneers in liquid biopsy

Haystack Oncology is based on over 20 years of liquid biopsy technology and clinical development led by the scientists specialized in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease therapy monitoring. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated billions of dollars in enterprise value.

Scientific Founders

HS-grid-items (2)
HS-grid-items (1)
ken-kinzler

Kenneth Kinzler, Ph.D.

Director, Ludwig Center at Johns Hopkins University Professor of Oncology
Dr. Kinzler received his Ph.D. from Johns Hopkins University School of Medicince and is now the co-director of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center... Learn more
nick-papadopoulos

Nick Papadopoulos, Ph.D.

Professor of Oncology
Dr. Papadopoulos is a professor of oncology and pathology at the Johns Hopkins University School of Medicine. His research focuses in translating the genetic information derived from cancer... Learn more

Leadership

Dan Edelstein Chief Executive Officer
Dan Edelstein is President and Chief Executive Officer at Haystack Oncology. Dan has over 15 years for liquid biopsy clinical development and commercialization experience. He was previously part of the team at Johns Hopkins that pioneered the use of circulating tumor DNA (ctDNA) to detect and track the progression of cancer...
Learn more
Frank Holtrup, Ph.D. Chief Technology Officer
Frank brings an extensive background in cancer functional genomics and diagnostic assay development to the team of Haystack Oncology, including more than a decade of experience in the liquid biopsy field. Prior to joining Haystack, Frank served in various operations and R&D leadership roles at Inostics and as Chief Scientific Officer...
Learn more
Joshua Cohen Chief Innovation Officer and Co-founder
With extensive experience in the fields of molecular genetics, cancer biology, and biomedical engineering, Joshua Cohen serves as the Chief Innovation Officer at Haystack Oncology.  Working in the lab of Drs. Bert Vogelstein and Kenneth Kinzler, Josh invented and developed the technology upon which Haystack’s Duo™ chemistry is based...
Learn more
Joel Kaufman Chief Financial Officer
Joel has overseen financial and business operations for multiple life sciences companies. Most recently, he served as Vice President of Finance & Corporate Development at Sema4, an AI-focused precision medicine company. Previously, Mr. Kaufman spent nearly four years in multiple roles, culminating...
Learn more
Matt Ryder Head of Clinical Diagnostic Development
Matt heads up diagnostic development at Haystack and has over a decade of experience in clinical genomics, including purpose-designed liquid biopsy testing, hereditary risk determination, and development and approval of novel companion diagnostics. At Haystack, he bridges our Research & Development Center...
Learn more
Hillary Sloane, Ph.D. Associate Director, Medical Affairs
Hillary is the Associate Director of Medical Affairs at Haystack Oncology, where she provides key clinical strategy support and primary oversight of the clinical development program. She engages closely with the medical community to establish and execute clinical development initiatives that specifically address current and...
Learn more
Avneet Heer, M.S. Associate Director of Market Access Strategy
Avneet joins Haystack with a deep experience in supporting diagnostic companies with global market access and policy, reimbursement and commercialization strategy, evidence development & value communication...
Learn more
Hannah Quinn Director of Laboratory Operations
Hannah Quinn serves as Director of Laboratory Operations at Haystack Oncology. Prior to joining Haystack, Hannah worked at Sysmex-Inostics where she was responsible for clinical laboratory operations, assay implementation, and study management. Before this, Hannah worked for a clinical sequencing laboratory at Johns Hopkins...
Learn more
Jared Snider, Ph.D. Director of Marketing
Jared comes to Haystack with the scientific background from a decade of cancer research combined with life science marketing expertise from over a decade in large biotech and small diagnostic startup marketing roles. Jared also co-founded Samba Scientific, a life science marketing agency serving genomic and...
Learn more
Robert Querfurth, Ph.D. Director of Technology Development
Robert brings an extensive background in molecular genetics and regulated assay development to the team of Haystack Oncology, including more than a decade of experience in the liquid biopsy field. Prior to joining Haystack, Robert served in various technical operations and R&D leadership roles at (Sysmex)-Inostics...
Learn more
Daniel Mehnert Director of Bioinformatics
Daniel Mehnert leads the bioinformatics department at Haystack Oncology, bringing an extensive background in cancer-related bioinformatics and long-running experience with NGS data analyis in the field of liquid biopies to the team of Haystack Oncology. Prior to joining Haystack, Daniel helped establish several liquid biopsy NGS products by leading the bioinformatics efforts...
Learn more
Jen Choiniere Director, Pharma Partnering & Strategic Alliances
Jen serves as the Director of Pharma Partnering and Strategic Alliances at Haystack Oncology, where she facilitates key collaborations to bring the promise of precision medicine closer to patients.  Jen has a background in law, as well as oncology diagnostics and drug development, previously serving in roles...
Learn more
Board of Directors

Executive Chairman

Isaac
Ro

Founder & Director

Dr. Nicholas
Papadopoulos

Director

Dan
Edelstein

Director

George C.
Petrocheilos

Director

R. Jacob
Vogelstein

Clinical Scientific Advisors

Haystack Oncology’s clinical advisory board brings a diversity of thought leadership among oncology experts, and is foundational to our mission of providing better MRD testing for better patient outcomes.

Chetan Bettegowda, MD, Ph.D​.

Professor of Neurosurgery and Oncology | Vice Chair, Department of Neurosurgery

Johns Hopkins School of Medicine

Al Benson​, MD

Professor of Medicine, Hematology and Oncology | NCCN Board of Directors | Chair, NCCN Hepatobiliary, Colon & Rectal Guidelines Panel | Member, NCCN Pancreatic Cancer and Neuroendocrine Panels

Northwestern University​

Nilofer Saba Azad​, MD

Professor of Oncology | Co-Director, Developmental Therapeutics Program/Phase I Program | NCCN Guidelines Panel, Colon Cancer

Johns Hopkins School of Medicine

Nishant Agrawal​, MD

Professor of Surgery​ | Chief of Otolaryngology-Head and Neck Surgery | Co-Director of Head and Neck Surgical Oncology

University of Chicago​

Afsaneh Barzi​, MD, Ph.D.

Associate Professor, Department of Medical Oncology & Therapeutics Research​ | Vice President, Quality and Value

City of Hope​/AcessHope

Peter Gibbs​, MD

Professor of Medicine​

Walter and Eliza Hall Institute

Jeanne Tie​, MD

Associate Professor of Medicine​

Walter and Eliza Hall Institute

Patrick Boland​, MD

Assistant Professor, Medical Oncology​

Rutgers Cancer Institute​

Andrea Cercek, MD

Associate Attending Physician | Section Head, Colorectal Cancer | Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers

Memorial Sloan Kettering Cancer Center

Richard Goldberg , MD

Emeritus Professor and Cancer Institute Director, West Virginia University | Associate Group Chair Alliance for Clinical Trials in Oncology

Chair, American Joint Commission on Cancer (AJCC) panel for the 9th edition of the AJCC Cancer Staging Handbook for the appendix, colon, rectum and anus

Cristian Tomasetti, PhD

Director, Center for Cancer Prevention and Early Detection, City of Hope

News & Events

The Latest

Find out what's happening at Haystack Oncology and stay up-to-date with industry news.

More news